PLSE
Pulse Biosciences Inc
NASDAQ: PLSE · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$21.17
+4.75% today
Updated 2026-04-30
Market cap
$1.48B
P/E ratio
—
P/S ratio
4,240.58x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$13 – $26
Volume
0.3M
Pulse Biosciences Inc (PLSE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.90M | $14.33M | $26.31M | $49.82M | $70.64M | $41.91M | $41.29M | $54.25M | $77.88M | $59.15M | $132.46M | $94.54M |
| Cash & equivalents | $7.01M | $3.61M | $2.09M | $3.39M | $51.10M | $6.90M | $12.46M | $28.61M | $61.14M | $44.37M | $118.04M | $80.73M |
| Current assets | $7.03M | $4.00M | $16.66M | $38.48M | $60.36M | $26.40M | $22.34M | $36.63M | $62.15M | $45.33M | $119.45M | $83.42M |
| Total liabilities | $1.82M | $659761.00 | $1.02M | $3.83M | $4.31M | $11.18M | $18.40M | $18.56M | $80.13M | $14.79M | $17.60M | $13.88M |
| Current liabilities | $164813.00 | $659761.00 | $1.02M | $2.21M | $3.11M | $4.46M | $7.58M | $8.52M | $5.98M | $6.71M | $10.05M | $7.92M |
| Long-term debt | — | — | $0.00 | $0.00 | — | — | — | — | $65.00M | — | — | — |
| Shareholder equity | $16.07M | $13.67M | $25.30M | $45.99M | $66.33M | $30.74M | $22.89M | $35.69M | $-2.25M | $44.36M | $114.86M | $80.66M |
| Retained earnings | $-276560.00 | $-3.09M | $-12.61M | $-38.17M | $-75.72M | $-122.69M | $-172.54M | $-236.20M | $-294.70M | $-336.92M | $-390.50M | $-463.28M |
| Accounts receivable | — | — | — | — | — | — | $0.00 | $61000.00 | $0.00 | — | — | $274000.00 |
| Inventory | — | — | $0.00 | $0.00 | — | — | $0.00 | $5.82M | $0.00 | — | — | $136000.00 |
| Goodwill | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M |